In-app Transfers, New Card Openings Remain Strong for Qi Card
BAGHDAD, Iraq, Sept. 26, 2020 /PRNewswire/ — Qi Card today announced that it has seen increases in two important...
Latest News
Eurecon Verlag: „Ranking Beste Pharma Unternehmen Deutschland – Internationale forschende Unternehmen“
MÜNCHEN–(BUSINESS WIRE)–Das Ranking der Top 10 „Beste Pharma-Unternehmen Deutschland“ steht fest. Es führt die nachhaltigsten und innovativsten Unternehmen in...
WeissLaw LLP Reminds JCAP and TRNE Shareholders About Its Ongoing Investigations
NEW YORK, Sept. 25, 2020 /PRNewswire/ — If you own shares in any of the companies listed above and...
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations
NEW YORK, Sept. 25, 2020 /PRNewswire/ — Montage Resources Corporation WeissLaw LLP is investigating possible breaches of fiduciary duty...
GOHEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against GoHealth, Inc. – GOCO
NEW ORLEANS, Sept. 25, 2020 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General...
SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations
NEW YORK, Sept. 25, 2020 /PRNewswire/ — If you own shares in any of the companies listed above and...
Eurecon Verlag: Ranking of the Best Pharmaceutical Companies in Germany – International Researching Companies
MUNICH–(BUSINESS WIRE)–The ranking of the “Best Pharmaceutical Companies in Germany” has been established. It comprises the 10 most sustainable...
Wire Harness Market – Roadmap for Recovery from COVID-19 | Increasing Automotive Sales to boost the Market Growth | Technavio
LONDON–(BUSINESS WIRE)–Technavio has been monitoring the wire harness market and it is poised to grow by $ 33.95 bn...
ENHERTU® Approved in Japan for the Treatment of Patients with HER2 Positive Metastatic Gastric Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the approval of...
FDA Approves KALYDECO® (ivacaftor) as First and Only CFTR Modulator to Treat Eligible Infants With CF as Early as Four Months of Age
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved KALYDECO® (ivacaftor) for...